MechanismsHumans
Genetic Evidence Suggests Combined Inhibition of Lipoprotein(a) and PCSK9 to Lower Atherosclerotic Cardiovascular Disease Risk.
AHA Scientific Sessions 2025 Abstract
The paper
Steinfeldt J, Kaisinger L, Buergel T et al.
AHA Scientific Sessions 2025 Abstract · 3 Nov 2025
Presented at AHA Scientific Sessions 2025 · Abstract 4368817
